Physician and researcher focused on structural heart disease, valvular driven heart failure, structural heart interventions.
Vienna, Austria
Joined December 2018
- Tweets259
- Following2K
- Followers1.7K
- Likes1.1K
Philipp E. Bartko retweeted
Grateful to @lpbadano for invitation to write bit.ly/TR_Review_EACVI
Together w/ @denisamuraru @pe_bartko @drmaisano Pepe Zamorano and @DonalErwan @ESC_Journals @EACVIPresident @escardio @ASE360 @iamritu @GilbertTangMD @ACCinTouch @HeartValveCntr @GeraldMaurer
Philipp E. Bartko retweeted
In Low Gradient AS, reduced GLS, increased ECV and LGE on CMR was associated with worse outcomes.
Comprehensive myocardial characterization using cardiac magnetic resonance associates with outcomes in low gradient severe aortic stenosis academic.oup.com/ehjcimaging…
Philipp E. Bartko retweeted
New multicenter TOPAS CMR study led by @Miho_Fukui_ and @PPibarot demonstrates the importance of phenotyping myocardial structural and function using #whyCMR in the complex group of low-gradient AS. Prognosis worsens with greater # of CMR risk markers. bit.ly/3yZGBr3
Philipp E. Bartko retweeted
Join @EdwardsLifesci in Paris or online for their #EuroPCR 2022 symposiums:
➡️"Valve in Valve and the journey starting with the first prosthesis" with @ValveDisease on May 17th
➡️"Learnings from an optimised #TAVI patient's journey" on May 18th
Sponsored post by @EdwardsLifesci
Philipp E. Bartko retweeted
Im Rahmen der Langen Nacht der Forschung können Sie eine von unseren @KardiologieWien ExpertInnen live-kommentierte minimal-invasive Herklappen-Implantation verfolgen!
Fr 20.5. 18:00
@MedUni_Wien / AKH Hörsaalzentrum
langenachtderforschung.at/st…
Philipp E. Bartko retweeted
GDMT titration conveys 3x higher chance to achieve improvement in secondary MR.
40% pts achieved #SMR reduction w/ ARNi and combinations of RASi, BB & MRA
Congrats @pe_bartko @ggoliasch
doi.org/10.1093/ehjci/jeac06…
#EHJCVI
@ESC_Journals
@GeraldMaurer
Philipp E. Bartko retweeted
Tricuspid regurgitation: what have we learnt? #EHJCVI
🚩 New nomenclature
🚩 New classification
🚩 New grading
🚩 New imaging approaches
doi.org/10.1093/ehjci/jeac00…
Fantastic leadership by @hahn_rt &collaboration @lpbadano @drmaisano @pe_bartko @DonalErwan JL Zamorano
#PCRTricuspid
Philipp E. Bartko retweeted
Thank you to my co-authors @lpbadano @denisamuraru @pe_bartko @drmaisano @PEPEZAMORANO and @DonalErwan: TR Review bit.ly/EHtJCVI_TRReview @ESC_Journals @escardio @ASE360 @echo_stepbystep @EGarciaSayan @robertomlang
Philipp E. Bartko retweeted
Excited to announce that my new provocative maneuver to detect PFO using party balloon during Saline Contrast Transthoracic Echocardiography has been published in JACC: Case Reports.
jacc.org/doi/10.1016/j.jacca…
Philipp E. Bartko retweeted
Topological mapping in secondary MR (sMR): #echofirst analysis shows importance of role of LA. Highest mortality in “small LV cavity” cluster. bit.ly/3GqrwiW
#vhdMR #cvVHD #JACCIMG #CardioTwitter #cvImaging #HFrEF @ValveDisease @pe_bartko @g_heitzinger @ggoliasch
Philipp E. Bartko retweeted
What are the key morphological and functional features in secondary mitral regurgitation?
@pe_bartko, @g_heitzinger, @ggoliasch et al from our @ValveDisease group present exciting novel data in @JACCJournals
jacc.org/doi/10.1016/j.jcmg.…
Philipp E. Bartko retweeted
"Unsupervised clustering supports the association of sMR with mortality predominantly driven by the small LV cavity phenotype, as previously suggested by a conceptional framework and termed disproportionate sMR"
jacc.org/doi/10.1016/j.jcmg.…
Philipp E. Bartko retweeted
The association of secondary MR with mortality cannot be purely attributed to cardiac morphology alone. From @jaccjournals jacc.org/doi/10.1016/j.jcmg.…
Philipp E. Bartko retweeted
Ever thought of preventing aortic stenosis (AS) instead having AVR or TAVI? Molecular mechanisms are unravelled and we will prevent AS like CAD. Statins do not work, but Lp(a) is a target in some, in others molecular mechanisms are deciphered - read it in the EHJ online!
Philipp E. Bartko retweeted
Stress FR during LDDSE is useful for the detection of AS severity & flow reserve & is associated with outcomes following aortic valve intervention @AVamvakidou @PPibarot @E_Guzzetti @pe_bartko @orwi @JoaoLCavalcante @BerglerKlein @cshenoy3 #AHAJournals ow.ly/cZZw50GIioZ
Philipp E. Bartko retweeted
In anticipation of #ASE21 this weekend, we'd like to share this AI on #EchoFirst. This frame-to-frame measurement of PLAX was fully automated by EchoNet-LVH. More examples and preprint soon! @ASE360 @CedarsSinai
Philipp E. Bartko retweeted
First come first serve for #euroecho on-site in Berlin. Limited number of seats. #eacvi This is one get his inscription! @escardio @alessia_gimelli @denisamuraru @Matte_Cameli @s_e_petersen @ThorEdvardsen @MarcDweck @JGrapsa @EACVIPresident
Philipp E. Bartko retweeted
Each 5mmHg reduction in systolic blood pressure lowered the relative risk of cardiovascular events by around 10%.
Authors, @kazemr et al, call for changes to global guidelines. hubs.li/H0MhDYV0 2/2
Philipp E. Bartko retweeted
Is raised #bloodpressure (BP) an inevitable and essential process of ageing is it time to remove #hypertension from our vocabulary and manage #CVD risk irrespective of an individual's BP into very old age?
doi.org/10.1016/S0140-6736(2…
doi.org/10.1016/S0140-6736(2…
#ESCCongress @TheLancet
Medication to lower high blood pressure should be an important treatment option to lower the risk of heart attack & stroke, regardless of age & across a wide range of blood pressures. – new @TheLancet paper from @kazemr & @TheBHF 👇
oxfordmartin.ox.ac.uk/news/l…
Philipp E. Bartko retweeted
#ESCGuidelines on VHD 2021 - homogenization of the cut-off values of EROA and RVol to define severe primary and secondary MR @EACVIPresident @PPibarot @ggoliasch @mirvatalasnag @lsanchisruiz @ASE360
